Day-to-day health care given by a health care provider
POPULARITY
Categories
656 episodes with Primary care
401 episodes with Primary care
247 episodes with Primary care
234 episodes with Primary care
167 episodes with Primary care
155 episodes with Primary care
83 episodes with Primary care
158 episodes with Primary care
72 episodes with Primary care
48 episodes with Primary care
33 episodes with Primary care
25 episodes with Primary care
47 episodes with Primary care
45 episodes with Primary care
35 episodes with Primary care
64 episodes with Primary care
35 episodes with Primary care
81 episodes with Primary care
53 episodes with Primary care
23 episodes with Primary care
24 episodes with Primary care
20 episodes with Primary care
20 episodes with Primary care
26 episodes with Primary care
29 episodes with Primary care
35 episodes with Primary care
23 episodes with Primary care
30 episodes with Primary care
21 episodes with Primary care
20 episodes with Primary care
17 episodes with Primary care
28 episodes with Primary care
14 episodes with Primary care
15 episodes with Primary care
31 episodes with Primary care
34 episodes with Primary care
21 episodes with Primary care
21 episodes with Primary care
14 episodes with Primary care
20 episodes with Primary care
13 episodes with Primary care
29 episodes with Primary care
13 episodes with Primary care
29 episodes with Primary care
22 episodes with Primary care
11 episodes with Primary care
248 episodes with Primary care
21 episodes with Primary care
17 episodes with Primary care
18 episodes with Primary care
13 episodes with Primary care
12 episodes with Primary care
9 episodes with Primary care
10 episodes with Primary care
8 episodes with Primary care
19 episodes with Primary care
35 episodes with Primary care
13 episodes with Primary care
20 episodes with Primary care
7 episodes with Primary care
16 episodes with Primary care
8 episodes with Primary care
11 episodes with Primary care
8 episodes with Primary care
20 episodes with Primary care
7 episodes with Primary care
10 episodes with Primary care
8 episodes with Primary care
6 episodes with Primary care
11 episodes with Primary care
7 episodes with Primary care
8 episodes with Primary care
8 episodes with Primary care
13 episodes with Primary care
6 episodes with Primary care
6 episodes with Primary care
7 episodes with Primary care
6 episodes with Primary care
9 episodes with Primary care
13 episodes with Primary care
5 episodes with Primary care
5 episodes with Primary care
8 episodes with Primary care
5 episodes with Primary care
10 episodes with Primary care
7 episodes with Primary care
10 episodes with Primary care
3 episodes with Primary care
7 episodes with Primary care
7 episodes with Primary care
8 episodes with Primary care
12 episodes with Primary care
6 episodes with Primary care
5 episodes with Primary care
7 episodes with Primary care
6 episodes with Primary care
7 episodes with Primary care
5 episodes with Primary care
3 episodes with Primary care
8 episodes with Primary care
6 episodes with Primary care
10 episodes with Primary care
10 episodes with Primary care
6 episodes with Primary care
5 episodes with Primary care
5 episodes with Primary care
3 episodes with Primary care
6 episodes with Primary care
4 episodes with Primary care
5 episodes with Primary care
3 episodes with Primary care
8 episodes with Primary care
5 episodes with Primary care
5 episodes with Primary care
6 episodes with Primary care
5 episodes with Primary care
9 episodes with Primary care
5 episodes with Primary care
5 episodes with Primary care
7 episodes with Primary care
5 episodes with Primary care
8 episodes with Primary care
7 episodes with Primary care
5 episodes with Primary care
5 episodes with Primary care
6 episodes with Primary care
4 episodes with Primary care
4 episodes with Primary care
3 episodes with Primary care
4 episodes with Primary care
4 episodes with Primary care
4 episodes with Primary care
5 episodes with Primary care
3 episodes with Primary care
9 episodes with Primary care
4 episodes with Primary care
10 episodes with Primary care
4 episodes with Primary care
5 episodes with Primary care
3 episodes with Primary care
5 episodes with Primary care
3 episodes with Primary care
4 episodes with Primary care
4 episodes with Primary care
3 episodes with Primary care
7 episodes with Primary care
7 episodes with Primary care
7 episodes with Primary care
5 episodes with Primary care
4 episodes with Primary care
3 episodes with Primary care
3 episodes with Primary care
3 episodes with Primary care
3 episodes with Primary care
4 episodes with Primary care
3 episodes with Primary care
5 episodes with Primary care
5 episodes with Primary care
5 episodes with Primary care
6 episodes with Primary care
4 episodes with Primary care
4 episodes with Primary care
4 episodes with Primary care
3 episodes with Primary care
4 episodes with Primary care
10 episodes with Primary care
8 episodes with Primary care
3 episodes with Primary care
2 episodes with Primary care
3 episodes with Primary care
7 episodes with Primary care
2 episodes with Primary care
5 episodes with Primary care
3 episodes with Primary care
3 episodes with Primary care
3 episodes with Primary care
6 episodes with Primary care
3 episodes with Primary care
3 episodes with Primary care
3 episodes with Primary care
3 episodes with Primary care
2 episodes with Primary care
2 episodes with Primary care
3 episodes with Primary care
3 episodes with Primary care
3 episodes with Primary care
6 episodes with Primary care
2 episodes with Primary care
7 episodes with Primary care
Featuring articles on PI3K-altered colorectal cancer, type 2 diabetes, oral semaglutide, and proportional-assist ventilation; a review article on tumor lysis syndrome; a case report of a girl with chest pain and bone and liver lesions; and Perspectives on integrating pharmacotherapy into tobacco control, on Medicaid enrollees with chronic conditions, and on ultraprocessed food.
Have you heard about people buying weight loss medications from unregulated sources online? The rise of black market weight loss drugs is putting lives at risk. In this episode, I discuss the concerning trend of people purchasing Retatrutide—a medication still in clinical trials—through illegal channels. Known as the "Godzilla Jab" for its potential power, early studies suggest this drug could help people lose up to 24% of their body weight. I explain what Retatrutide is and how it compares to FDA-approved medications like Ozempic, Wegovy, Zepbound, and Mounjaro. We explore why people take dangerous risks with black market drugs, from social media hype to cost concerns and access issues. Most importantly, I share the serious health and legal risks of buying unregulated medications and provide clear guidelines for safely accessing weight loss treatments through licensed providers. Tune in to learn how to protect yourself and make informed decisions about weight loss medications the safe way. Episode Highlights: What is Retatrutide The dangers of purchasing unregulated medications online Factors driving people to illegal sources Legal risks of buying unapproved drugs and potential health complications from unregulated substances Safe Medication Practices Understanding that medication works best when combined with healthy eating, physical activity, adequate rest, and emotional support Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
It seems there are news stories every week about the accelerating pace of innovation in gene therapy, but only about 50 therapies have been approved so far by the US Food and Drug Administration. Our guest today, Dr. Bobby Gaspar, leads a UK-based biotech company, Orchard Therapeutics, that developed one of those treatments using gene-modified stem cells in your blood that self-renew, so a single administration can give you potentially a lifelong effect. “Our approach is about correcting those hematopoietic stem cells and allowing them to give rise to cells that can then correct the disease,” explains Dr. Gaspar. The therapy in focus is lenmeldy, the first approved treatment for metachromatic leukodystrophy, also known as MLD, a devastating inherited disorder that affects roughly 600 children worldwide. But Dr. Gaspar is optimistic that learnings from Orchard's work on MLD could be useful in treating much more common disorders including frontotemporal dementia, Crohn's disease and others. This highly informative conversation with host Lindsey Smith also explores the importance of newborn screening, community collaboration in advancing clinical trials for rare diseases, and a future in which each gene therapy will be used as a tool for specific applications. “There will be many gene therapies available, some of which will become the standard of care for certain diseases, but it won't be for every disease.”Mentioned in this episode:Orchard Therapeutics If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
This special episode of The Doctor's Playbook steps outside the usual clinical lens to explore the ethical, spiritual, and human dimensions of medicine. My guest is The Reverend Clayton L. Thomason, J.D., M.Div., who holds the Bishop Anderson Endowed Chair of Religion and Ethics in Medicine at Rush University Medical Center, where he serves as Chair of the Department of Religion, Health & Human Values and Director of the Healthcare Ethics Program.Rev. Thomason's career bridges law, theology, and medicine. He has chaired state commissions on end-of-life care, served on national ethics boards, and spent decades guiding clinicians, patients, and families through some of healthcare's most profound dilemmas. His work focuses on community-based research addressing health disparities, the role of virtue in professional development, and public policy in palliative and end-of-life care.In our conversation, we talk about what it means to be human in medicine, how ethics and spirituality influence the care we provide, and the stories that have shaped his career. This episode is not just about medicine — it's about meaning, values, and the questions that stay with us long after a case is closed.Lead Host: Andrew MohamaGuest: Reverend Clayton L. Thomason, J.D., M.Div.Produced By: Andrew MohamaAlert & Oriented is a medical student-run clinical reasoning podcast dedicated to providing a unique platform for early learners to practice their skills as a team in real time. Through our podcast, we strive to foster a learning environment where medical students can engage with one another, share knowledge, and gain valuable experience in clinical reasoning. We aim to provide a comprehensive and supportive platform for early learners to develop their clinical reasoning skills, build confidence in their craft, and become the best clinicians they can be.Follow the team on X:A&OAndrew MohamaRich AbramsConnect on LinkedInAndrew MohamaA fantastic resource, by learners, for learners in Internal Medicine, Family Medicine, Pediatrics, Primary Care, Emergency Medicine, and Hospital Medicine.
Featuring articles on hypertrophic cardiomyopathy, rehabilitation after myocardial infarction in older adults, the 2024 Marburg virus disease outbreak in Rwanda, and medications for opioid use disorder in county jails; a case report of a woman with dyspnea and fatigue; a Medicine and Society on the race-correction debates; and Perspectives on recent efforts toward equity, on medical research funding in a divided America, and on the end of days.
Amanda Janitz is an associate professor at the University of Oklahoma Health Sciences Hudson College of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.E. Janitz and Others. Improving Care Coordination for Indigenous Patients with Cancer. N Engl J Med 2025;393:940-942.
D.O. or Do Not: The Osteopathic Physician's Journey for Premed & Medical Students
Send us a textIn this episode, we will interview Dr. Thomas Cavaliere, the current Dean of the Rowan Virtua School of Osteopathic Medicine. Dr. Cavaliere graduated from the Des Moines University College of Osteopathic Medicine, following which he completed an internal medicine residency at Thomas Jefferson University Hospital. Under his leadership, the Rowan Virtua School of Osteopathic Medicine has been named one of the best medical schools in the country for primary care and geriatric medical education. Dr. Cavalierey has also recently been selected to serve as the inaugural Senior Vice Provost of the Virtua Health College of Medicine and Life Sciences, as well as the Chief Academic Officer for the Virtua Health System. It is an honor to interview such an accomplished physician, and we believe his perspectives are valuable for everyone from pre-medical students to attending physicians. Dr. Cavaliere will discuss the advantages of pursuing a career in academic medicine, emphasizing the opportunity to combine clinical practice with teaching and research, and the fulfillment of caring for patients while training the next generation of physicians. We know you will love this episode.
Listen as pulmonologist Peter Dicpinigaitis discusses his approach to the diagnosis and management of patients with refractory chronic cough in the context of a clinically relevant case and provides insights regarding emerging therapies.PresenterPeter Dicpinigaitis, MDProfessor of MedicineAlbert Einstein College of MedicineDivision of Critical Care MedicineMontefiore Medical CenterDirector, Montefiore Cough CenterBronx, New YorkLink to full program:https://bit.ly/4kweynG
Abby Frye, PharmD, BCACP, Clinical Pharmacy Specialist,Primary Care, Providence Medical Group, Providence St. VincentCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/ywBS3NqHMf (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: September 9, 2025End Date: September 9, 2026
Abby Frye, PharmD, BCACP, Clinical Pharmacy Specialist,Primary Care, Providence Medical Group, Providence St. VincentCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/ywBS3NqHMf (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: September 9, 2025End Date: September 9, 2026
A tick bite in Maine leads to an unexpected diagnosis, challenging our understanding of alpha-Gal syndrome's geographic boundaries. This episode unravels the expanding reach of this unique allergic condition, now found from coast to coast and linked to multiple tick species. We explore recent case studies that highlight the need for increased clinical suspicion, even in non-endemic areas. Learn about the diverse symptom presentation, from delayed anaphylaxis to chronic urticaria and GI distress, and the potential cardiovascular implications. Discover how alpha-Gal syndrome intersects with common medications and why it's becoming a crucial consideration in idiopathic anaphylaxis and IBS workups. Gain insights into emerging diagnostic approaches and legislative efforts to address this growing public health concern. Resources and references available at: https://www.thermofisher.com/phadia/us/en/resources/immunocast/unmasking-alpha-gal-new-vectors-regions-concerns.html?cid=0ct_3pc_05032024_9SGOV4
Alzheimer's Disease Early Diagnosis and Management Evaluation and Credit: https://www.surveymonkey.com/r/medchat82 Target Audience This activity is targeted toward primary care physicians and advanced providers. Statement of Need A special report of Alzheimer's Disease Facts and Figures published in 2017, indicated 4 out of 5 Americans would want to know if they had Alzheimer's disease before it impacted their life. With the aging population the incidence of Alzheimer's is growing, according to the Alzheimer's Association over 7 million Americans are living with AD. This program will focus on screening and dx of AD in the early stages especially in pc offices, where patients will first present with cognitive symptoms. Additionally, this podcast will highlight the new blood biomarker test recently approved and its indications. Objectives Differentiate between normal cognitive aging, mild cognitive impairment and early-stage Alzheimer's disease. Identify appropriate cognitive screening tools for use in primary care and their role in the early identification of Alzheimer's disease. Explain the mechanism and clinical relevance of blood-based biomarkers in the diagnosis of Alzheimer's disease, including the current guidelines and emerging practices. ModeratorRachel Hart, D.O. Geriatric Medicine Physician Memory and Cognitive Disorders Specialist Norton Neuroscience Institute Memory Center SpeakerGreg E. Cooper, M.D., Ph.D. Chief, Adult Neurology Medical Director, Memory Center Norton Neuroscience Institute Planner Disclosure The planners of this activity do not have any relevant financial relationships with ineligible companies to disclose. Moderator and Speaker DisclosureThe moderator, Gregory Cooper, M.D., Ph.D., discloses relevant financial relationships with Eli Lilly and Eisai (research). The speaker, Rachel Hart, D.O., discloses a relevant financial relationship with Eli Lilly (faculty). All relevant financial relationships have been successfully mitigated. Commercial Support There was no commercial support for this activity. Physician CreditsAccreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Credits Norton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.50 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance. For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org. Resources for Additional Study/ReferencesAmerican Perspectives on Early Detection of Alzheimer's Disease in the Era of Treatment https://www.alz.org/alzheimers-dementia/facts-figures Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care https://pubmed.ncbi.nlm.nih.gov/39068545/ Date of Original Release | Sept. 2025; Information is current as of the time of recording. Course Termination Date | Sept. 2028 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.
This episode features Dr. Adam Breslow, President and CEO of Children's Primary Care Medical Group, who shares insights on advancing team wellness, expanding access to care, and investing in technology to support pediatric patients and clinicians alike. He also reflects on leadership, advocacy, and the future of thriving healthcare organizations.
In this episode of The Doctor's Playbook, we sit down with Dr. Sonali Khurana—academic hospitalist, educator, and core faculty at Rush University Medical Center. With a career spanning oncology hospitalist care, medical education leadership, and quality improvement, she brings a wealth of insight into both the bedside and the classroom.We explore her clinical reasoning frameworks, the lessons oncology has taught her about seeing patients as whole people, and why debriefing difficult cases is essential for both patient care and physician well-being. Dr. Khurana also shares her journey as a teacher and reflects on how parenthood and partnership in medicine have shaped her approach.Whether you're a student navigating uncertainty, a resident honing diagnostic skills, or an attending striving to teach and connect, this episode offers grounded wisdom on practicing medicine with clarity, humility, and humanity.Lead Host: Andrew MohamaGuest: Sonali Khurana, MDProduced By: Andrew MohamaAlert & Oriented is a medical student-run clinical reasoning podcast dedicated to providing a unique platform for early learners to practice their skills as a team in real time. Through our podcast, we strive to foster a learning environment where medical students can engage with one another, share knowledge, and gain valuable experience in clinical reasoning. We aim to provide a comprehensive and supportive platform for early learners to develop their clinical reasoning skills, build confidence in their craft, and become the best clinicians they can be.Follow the team on X:A&OAndrew MohamaConnect on LinkedInAndrew MohamaA fantastic resource, by learners, for learners in Internal Medicine, Family Medicine, Pediatrics, Primary Care, Emergency Medicine, and Hospital Medicine.
On today's podcast, we talk about an innovative specialized primary care model for older veterans called the Geriatric Patient Aligned Care Team (GeriPACT) program. It's designed with smaller patient panels and enhanced social worker and pharmacist involvement, and its approach is aimed at improving care and outcomes for our aging population. We unpack the intriguing findings of a recent JAMA Network Open study authored by one of our guests, Susan “Nicki” Hastings, looking at GeriPACT that compares it to a traditional Patient Aligned Care Team (PACT). While GeriPACT successfully delivered more attention to geriatric conditions, it surprisingly didn't translate into expected improvements like more time at home or better self-rated health. We discuss the potential reasons behind this with our other two guests, one a geriatrics fellow, Kristie Hsu, and the other a recurring guest and host of the podcast, Ken Covinsky. Was it just that it didn't work, or were there other things going on, from the intensity of "usual care" to the challenges of measuring complex health outcomes and the possibility that 18 months simply wasn't long enough to see the full benefits? Despite what was ostensibly a negative trial, we highlight some reassuring aspects and future hopes for GeriPACT and how we can all incorporate some of these components into the care of our patients. We'll also pose critical questions for future research, emphasizing why continued development and evaluation of new care models are essential for the health of our older population.
You are in for a dose of inspiration in this episode of Raise the Line as we introduce you to a rare disease patient who was a leading force in establishing the diagnosis for her own condition, who played a key role in launching the first phase three clinical trials for it, and who is now coordinating research into the disease and related disorders at one of the nation's top hospitals. Rebecca Salky, RN, was first afflicted at the age of four with MOGAD, an autoimmune disorder of the central nervous system that can cause paralysis, vision loss and seizures. In this fascinating conversation with host Lindsey Smith, Rebecca describes her long and challenging journey with MOGAD, her work at the Neuroimmunology Clinic and Research Lab at Massachusetts General Hospital, and the importance of finding a MOGAD community in her early twenties. “There's a sense of power and security when you have others on your side. You're not alone in this journey of the rare disease,” she explains. Be sure to stay tuned to learn about Rebecca's work in patient advocacy, her experience as a nurse, and the three things she thinks are missing in the care of rare disease patients as our Year of the Zebra series continues.Mentioned in this episode:The MOG ProjectNeuroimmunology Clinic & Research Lab at Mass General If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
This week on Faisel and Friends, we are discussing From Inspiration to Impact: Family Medicine at the Crossroads of Change. Faisel and Dan are talking with Shawn Martin, Executive Vice President and CEO of the American Academy of Family Physicians, and Dr. Tina Sharma, Chief Resident of Family Medicine at The University of Texas at Tyler.Our conversation explores the growing direct primary care movement, the utilization of artificial intelligence in medicine, and the bright future workforce of Family Medicine.This episode was recorded live at FUTURE, the AAFP's annual conference! Learn more about FUTURE here: https://www.aafp.org/events/future-conference/2026.html
See omnystudio.com/listener for privacy information.
Featuring articles on obesity, type 1 diabetes, syphilis, and heparin-induced thrombocytopenia; a review article on the management of acute type B aortic dissection; a Clinical Problem-Solving describing a fruitful workup; and Perspectives on the corporatization deal, on advancing physician-scientist training in China, and on the rise of drug innovation in China.
Amitabh Chandra is a professor of public policy at the Harvard Kennedy School of Government and a professor of business administration at Harvard Business School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Chandra and M. Shepard. The Corporatization Deal — Health Care, Investors, and the Profit Priority. N Engl J Med 2025;393:833-835.
Welcome back to Ditch the Lab Coat! In this episode, host Dr. Mark Bonta sits down with Dr. William Cherniak, an emergency physician, global health leader, and CEO of Rocket Doctor—a Canadian tech company on a mission to shake up how we access healthcare. As the world continues to grapple with the lessons learned from COVID-19, Dr. Cherniak and Dr. Bonta dive deep into the evolution of virtual care and its role in both episodic and chronic healthcare.Together, they challenge the misconceptions around virtual medicine, exploring how digital innovation is not just a convenient alternative but often a superior solution for patients who need fast, efficient, and ongoing medical attention. From navigating Canada's complex healthcare policies to leveraging AI and Bluetooth-enabled devices, Dr. Cherniak shares his journey as a physician-entrepreneur working to make healthcare more accessible—whether you're managing blood pressure from your living room or urgently treating poison ivy without a trip across town.Tune in as we unravel the myths of hands-on-only healthcare, the future possibilities of remote diagnostics and procedures, and what it will take for medicine to truly enter the 21st century. If you're curious about how virtual care is changing the patient-doctor relationship, cutting through red tape, and building a compassionate, tech-savvy future, this is an episode you can't miss.(https://www.linkedin.com)(http://rocketdoctor.io/)Episode Lessons 1 – Virtual Care Is Effective – Virtual healthcare can match or even surpass in-person care for many conditions, especially when accessibility is an issue.2 – Breaking Down Healthcare Barriers – Virtual care improves access for patients struggling with long waits or limited transportation to clinics.3 – Episodic vs. Chronic Care Needs – Healthcare isn't just for chronic patients; episodic care can be efficiently managed through modern virtual models.4 – Innovation Born From Necessity – Rocket Doctor's creation was driven by gaps in primary care, especially for those without family doctors.5 – Team-Based Medical Support – Virtual platforms enable teams of physicians to support each other, ensuring continuity even when one doctor is away.6 – Navigating Bureaucracy and Policy – Different provinces and health systems determine how virtual care can be provided and reimbursed, affecting implementation.7 – Seeing Beyond Clinic Walls – Virtual visits provide unique insights into patients' home and social environments, revealing valuable context for care.8 – Tech Empowers Doctors and Patients – Electronic records, AI tools, and Bluetooth devices streamline tasks, allowing more focus on patient care and faster follow-up.9 – Busting Medical Tradition Myths – Not every visit needs physical examination; much required care can be accurately delivered without in-person touch.10 – Envisioning Healthcare's Future – Real integration of AI, seamless records sharing, and patient-driven portals will further revolutionize how care is delivered virtually.Want me to bold all the lesson titles for consistency, or keep only the last one bold as the highlight?Episode Timestamps00:00 – Medical Podcast Disclaimer 05:28 – Reimagining Virtual Care in Canada 08:04 – Canadian Tech-Driven Medical Practice 11:54 – Bureaucratic Challenges in Healthcare 13:39 – Embracing Virtual Healthcare 19:53 – Virtual Care: Beneficial vs. In-Person 20:54 – Canada's Acute vs. Preventative Care 26:14 – Virtual Care Evolution 2019 30:08 – Healthcare Innovation and Streamlining 32:59 – Home Ultrasound Study for Pneumonia 35:40 – Virtual Care: Medicine's Evolution 37:42 – Science Skepticism Podcast Promo DISCLAMER >>>>>> The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions. >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests. Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University.
Send us a textKey Opinion Leaders Manal Abdelmalek, Naim Alkhouri, Scott Isaacs and Zobair Younossi join Roger Green to discuss the FDA's approval of semaglutide for patients with non-cirrhotic MASH. This conversation centers on the roles that new technologies and an expanded APP population will play in MASLD and MASH management in the US, and concludes by exploring how care might look different 12 months from now, and then in subsequent years. As panelists identify some of the changes they foresee if we are to manage the tsunami of undiagnosed MASLD patients, many comments touch on themes discussed earlier in this episode. A couple are unique. Zobair and Scott discuss the increased role that artificial intelligence and big data analytics will play in identifying high-risk patients and improving clinical pathways. Additionally, Zobair notes that we must remember that the vast majority of MASLD patients will never develop MASH. Manal foresees a more sophisticated approach to selecting pharmacotherapies as prescribers have a broader set of options, each with its own benefits and drawbacks. Scott anticipates a "paradigm shift" in which endocrinologists view MASH similarly to how they view retinopathy, neuropathy and retinopathy. Naim suggests that one year will not look tremendously different from today, but that five years from now will be an entirely different picture, which he describes in some detail.
Your liver could be silently struggling right now and the good news is, you can turn it around. In this episode, I dive deep into the topic of metabolic dysfunction-associated steatotic liver disease, also known as fatty liver disease. I explain what it is, why the medical community updated the name, and why it matters for long-term health. I highlight who is most at risk, including people with obesity, diabetes, high blood pressure, or high cholesterol and why the condition is often called a “silent disease” since many don't realize they have it. I also break down the potential dangers if it progresses, from inflammation to cirrhosis, and share the encouraging news that it's often reversible with lifestyle changes. My goal is to empower listeners to protect their liver and overall health with small, sustainable changes. Take control of your health and tune in to this episode to learn how you can prevent, reverse, and protect your liver from fatty liver disease with simple, sustainable steps! Episode Highlights: What MASLD is and why the name changed from NAFLD Why fatty liver disease is becoming more common and who's most at risk Signs, symptoms, and why it's often called a “silent disease” Potential complications, including inflammation, fibrosis, and cirrhosis How fatty liver is diagnosed through blood tests, imaging, or scans Lifestyle strategies to reverse or prevent progression The role of managing diabetes, cholesterol, and blood pressure in protecting liver health FDA-approved medications such as Wegovy and others that may help in treatment Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
In this episode of Leadership Bites, Guy Bloom interviews Erin Lee, the CEO of Flow Neuroscience, a company that has developed a wearable headset designed to treat depression through mild electrical stimulation of the brain. Erin shares her journey into the healthcare sector, the science behind the headset, and the promising results from clinical trials. The conversation explores the integration of Flow's technology with traditional treatments, the challenges faced in the medical community, and the potential future applications of this innovative approach to mental health. Erin emphasizes the importance of accessibility and affordability in mental health treatments, and the episode concludes with a call to action for listeners to explore Flow Neuroscience's offerings.TakeawaysErin Lee runs a neuroscience company that treats depression with electricity.The Flow headset is a wearable device that stimulates the brain.Clinical trials have shown a 75% drop in suicidal ideation.Erin's background includes experience in healthcare and tech companies.The headset works for 50-70% of users in treating depression.Flow can be used alongside traditional antidepressants.The technology aims to be accessible and affordable for all.Primary care clinicians are increasingly open to using Flow.The future of mental health treatment may include more personalized approaches.Flow is exploring applications for conditions like autism and ADHD.Sound Bites"We saw a 75% drop in suicidal ideation.""We can fit into a treatment for you that works.""We're not anti-drug, we're anti-depression."Chapters00:00 Introduction to Flow Neuroscience02:55 The Science Behind the Headset06:05 Erin's Journey to Flow Neuroscience08:48 The Founders and Their Vision12:03 Understanding the Technology14:49 Integration with Traditional Treatments17:46 The Future of Mental Health Treatment20:45 Educating Healthcare Professionals24:09 Strategic Targeting and Clinician Response26:53 Challenges in Primary Care vs Psychiatry29:50 The Role of Data in Treatment Effectiveness31:45 Exploring Applications in Autism and Neurodivergence34:01 The Future of Technology in Mental Health35:57 Understanding the Use of Flow for Well Individuals38:46 Integrating EEG for Personalized Treatment42:45 Concluding Thoughts and Future DirectionsTo find out more about Guy Bloom and his award winning work in Team Coaching, Leadership Development and Executive Coaching click below.The link to everything CLICK HEREUK: 07827 953814Email: guybloom@livingbrave.com Web: www.livingbrave.com
Disclaimers: THIS SITE AND ANY OTHER CMT MANAGED OR OWNED WEB PROPERTY by Concierge Medicine Today, LLC (herein CMT) DOES NOT OFFER MEDICAL, FINANCIAL, LEGAL, OR OTHER PROFESSIONAL ADVICE. ERRORS OR OMISSIONS MAY OCCUR ON THIS SITE. The content is primarily designed for general informational purposes, targeting a healthcare professional audience. Any references, links, or interviews should not be construed as endorsements. CMT is not responsible for errors, omissions, statements, conduct, or claims related to guest posts, op-eds, podcasts, press releases, sponsored job listings, or advertised opportunities. Typically, CMT will strive to remove job listings that are older than four months, but this is not guaranteed. Always consult with reliable advisors before acting on the information you find here. By using our web properties, content, events, etc., in whole or in part, you agree to comply with the Terms and Conditions and Privacy Policy found here, releasing Concierge Medicine Today, LLC (CMT) from all liability. Additional terms may be applicable. CMT retains the right to remove any content, images, interviews, graphics, job listings, and similar materials at its discretion at any time, without notice and without liability. Thank you.
Welcome to our third episode of the Early Clinical Learners Series - a series dedicated towards fostering clinical reasoning skills and strategies in early clinical learners. This episode is sponsored by LearningCortex - visit www.learningcortex.com to start learning smarter today!Hosts: Caroline Wang, Andrew Mohama, Mohan Bhadriraju Guests: Nicole Glick, John KimProduced By: Caroline Wang, Andrew MohamaAlert & Oriented is a medical student-run clinical reasoning podcast dedicated to providing a unique platform for early learners to practice their skills as a team in real time. Through our podcast, we strive to foster a learning environment where medical students can engage with one another, share knowledge, and gain valuable experience in clinical reasoning. We aim to provide a comprehensive and supportive platform for early learners to develop their clinical reasoning skills, build confidence in their craft, and become the best clinicians they can be.Follow the team on Twitter:A&OA fantastic resource, by learners, for learners in Internal Medicine, Family Medicine, Pediatrics, Primary Care, Emergency Medicine, and Hospital Medicine.
In this episode, Dr Tsen Vei Lim talks to Dr Katie East, an Associate Professor in Public Health within the Department of Primary Care and Public Health at Brighton and Sussex Medical School in the UK. The interview covers her and her co-authors research report on a randomised online experiment evaluating the impact of vaping fact films on vaping harm perceptions among UK young adults, as well as discussing the broader misconceptions around vaping and the importance of expert-led health messaging. · How vapes differ from conventional tobacco smoking [1:31]· Some misconceptions around vaping [02:07]· What do people know about nicotine? [03:20]· The vaping fact films and addressing the common myths around vaping [04:20]· The key findings of the study [06:06]· The importance of expert messaging in correcting perceptions on vaping [07:27]· Where can we find the vaping fact films? [08:22]· How can we combat misconceptions in vaping? [09:30]· Whether governments have a role in addressing vaping misconceptions [10:52]· The strategies to help people quit smoking that include vapes [12:13]· The evidence on these strategies [13:10]· How the collaborators found the experience in creating the videos [14:14]About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge (UK) and a BSc in Psychology from the University of Bath (UK). About Katie East: Katie is an Associate Professor in Public Health within the Department of Primary Care and Public Health at Brighton and Sussex Medical School. She also has a visiting appointment at King's College London (KCL), where she recently completed her SSA Fellowship on the topic of vaping harm perceptions. In 2024, she was awarded the SSA's Fred Yates Prize for significant contributions to work in the field of addiction. Her research focuses on nicotine and tobacco product use, perceptions, and policies.The authors have no conflicts of interest to disclose. Original article: Evaluating the impact of vaping facts films on vaping harm perceptions among young adults in the UK: A randomized on-line experiment - https://doi.org/10.1111/add.70119 The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.
Right up front here, let me just state loudly that there are some amazing independent TPAs (third-party administrators) out there who have the expertise, the scrappy willfulness, and the deep desire to do right by their clients, their self-insured employer clients. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. And look, they may be facing some of the same headwinds that plan sponsors themselves face, like anticompetitive contracts, brokers who are up to no good, etc. So, just keep that in mind as you listen. And the main point of all of this if you are a plan sponsor is, find a good TPA partner, which, as Bryce Platt has said about consultants but same rules apply about TPAs here, the difficulty is being informed enough to tell the difference. So, the goal of this show is to help with that, the “be informed enough to tell the difference.” All of this being said, this is technically a Take Two; but we trimmed it down and welcome to a whole new intro. So, call this a refresher and an update about a really, really important topic from last year that is becoming extremely (maybe even more) relevant this year. Really relevant. Consider, for example, the show with Claire Brockbank (EP453) about carrier/TPA RFPs (requests for proposal) and all of the landmines that are really expensive, that are buried in some of these contracts. Then there was the Cynthia Fisher show (EP457) from last year about the millions, maybe billions of dollars in aggregate going missing in medical (ie, TPA or ASO [administrative services only]) spread pricing. We had “The Mystery of the Weekly Claims Wire” show with Justin Leader (EP433), again, revealing money that's being disappeared when the TPA is withdrawing dollars from plan sponsor checking accounts. And then there's the payment integrity episode with Kimberly Carleson (EP480) from a few weeks ago with just another wrinkle on this, namely TPAs or ASOs who insist on auditing themselves and how that turns out for members and plan sponsors. Oh, and last, but certainly not least, is the whistleblower show with Ann Lewandowski (EP476) on how a TPA arm of an EBC (employee benefit consultant) allegedly pocketed $20 million—$20 million of their client's pharma rebates—and used that $20 million to fund their executive bonus pool. What a time to be alive! All of this just highlights the huge stakes for plan sponsors to really understand what their TPA is all about. And when I say high stakes, I mean from both a legal standpoint and also just vast dollars in play here. But this episode with Elizabeth Mitchell is also, I'm gonna say, extremely relevant given just a few ripped from the headlines and news articles such as these. I'm gonna start actually with a post from Kimberly Carleson, and I like the comment by Jeff Evans, who wrote, “How does $8,710 equal $104,266?” Spoiler alert, it doesn't. Lots of missing dollars there. Someone's hands are in the cookie jar. Oh, look, the TPA has entered the chat. In a nutshell, and I'm quoting something Peter Hayes wrote, he wrote, “TPAs have received relatively little public attention. [There's an article in Health Affairs] that describes how TPAs impose hidden fees, benefit from their own form of spread pricing, and otherwise prioritize their own financial interests over those of their plan clients.” Also, here's a totally other issue. Let me quote Luke Prettol highlighting something Jason Shafrin had written about a paper by Jeff Marr, Daniel Polsky, and Mark Meiselbach. Let me slightly rephrase what Luke said. He wrote, “Employers pay, on average, a 4.7% [so almost 5%] price markup when hospitals are in their TPA's [Medicare Advantage] network.” Right? Dr. Eric Bricker talked about this in that episode (EP472) just how TPAs with MA (Medicare Advantage) business negotiate their commercial clients to pay higher rates so that then they can pay lower rates for their own MA members. As Luke wrote, “On its face, this overpayment does not appear to be solely in the interest of participants.” No kidding. Now, let's spin the wheel here. There are barriers for TPAs themselves, even the ones who have a deep desire to do the right thing. As Patrick Moore wrote, “Most TPAs still can't do [many of the things that employers might want because there are] PPO contracts.” So, is it a rock in a hard place situation? I mean, if the TPA has no other options than using a carrier's PPO (preferred provider organization) network with all its attendant contractual issues, then yeah, that is one definite challenge. Along these lines, let me read a post by Rina Tikia, because I think she sums up this really well. “When independent TPAs … push for transparency, they're blocked under the banner of ‘fiduciary risk.' “Meanwhile, the largest carriers and PBMs, with Cayman shell subsidiaries, DOJ kickback probes, [huge] hedge fund ties, [$10 million-plus] lobbying budgets, and antitrust violations continue unchecked. They are not only allowed to operate but celebrated as mainstream options. “Why the double standard? Political donations? Foundation smokescreens? Nonprofit status as a PR shield?” These are excellent questions. And here's another challenge: brokers. Ramesh Kumar Budhani wrote about this one, just how hard it is sometimes to find—for TPA, an independent TPA, trying to do the right thing—to find brokers who prioritize doing the right thing for employers and helping their clients save money. The summary of all of this: There are TPAs and there are ASOs who aren't even trying. They are going to ride the flywheel, the gravy train, and catch all of the dollars flying off of it for as long as they can manage to cling to it with all 10 of their fingers. Then there are TPAs, mostly indies, trying super hard to do the right thing. But how successful they are is going to depend on how boxed in they are by the PPO networks or the carriers that the brokers or even plan sponsors may insist on. Just how courageous they are and just how smart they are and experienced they are about the market and how it actually operates. So, the show that follows is about all of this, including how we can inspire TPAs, which, in the show that follows, subsumes ASOs kind of into it. But in the show that follows, I hope it's inspiring to create an environment so that the market demands TPAs that do all of the things, and we make inertia not a viable business strategy. Elizabeth Mitchell, my guest today, currently serves as the president and CEO of the Purchaser Business Group on Health. Also mentioned in this episode are Purchaser Business Group on Health; Bryce Platt; Claire Brockbank; Cynthia Fisher; Justin Leader; Kimberly Carleson; Ann Lewandowski; Jeff Evans; Peter Hayes; Luke Prettol; Jason Shafrin; Jeff Marr; Daniel Polsky; Mark Meiselbach; Eric Bricker, MD; Tom Nash; Patrick Moore; Rina Tikia; Ramesh Kumar Budhani; Mark Cuban; Harold Miller; Chris Deacon; Moby Parsons, MD; Benjamin Schwartz, MD, MBA; Mishe Health; Rik Renard; and Cora Opsahl. You can learn more at PBGH and by connecting with Elizabeth on LinkedIn. Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health (PBGH), advances its strategic focus areas of advanced primary care, functional markets, and purchasing value. She leads PBGH in mobilizing health care purchasers, elevating the role and impact of primary care, and creating functional healthcare markets to support high-quality affordable care, achieving measurable impacts on outcomes and affordability. At PBGH, Elizabeth leverages her extensive experience in working with healthcare purchasers, providers, policymakers, and payers to improve healthcare quality and cost. She previously served as senior vice president for healthcare and community health transformation at Blue Shield of California, during which time she designed Blue Shield's strategy for transforming practice, payment, and community health. Elizabeth served as the president and CEO of the Network for Regional Healthcare Improvement (NRHI), a network of regional quality improvement and measurement organizations. She also served as CEO of Maine's business coalition on health (the Maine Health Management Coalition), worked within an integrated delivery system (MaineHealth), and was elected to the Maine State Legislature, serving as a State Representative. Elizabeth served as vice chairperson of the U.S. Department of Health and Human Services Physician-Focused Payment Model Technical Advisory Committee, board and executive committee member of the National Quality Forum (NQF), member of the National Academy of Medicine's “Vital Signs” Study Committee on core metrics, and a guiding committee member for the Health Care Payment Learning & Action Network. Elizabeth holds a degree in religion from Reed College and studied social policy at the London School of Economics. 08:06 What is the overarching context for health plans in healthcare purchasing? 11:31 Why is it important to reestablish a connection between the people paying for care and people providing care? 13:47 What are the needs of a self-insured employer when managing employee benefits? 19:00 Is it doable for employers to set their own contracts? 21:24 Is transparency presumed? 22:39 Will the new transparency upon us actually expose wasted expense? 24:23 EP408 with Chris Deacon. 25:58 “This is not about individual bad actors. … The systems … that is not aligned.” 27:39 Are there providers who want to work directly with employers? 30:53 Why is it important that incentives need to be aligned? 32:42 EP427 with Rik Renard. 33:51 What's missing from the conversation on changing health plans? You can learn more at PBGH and by connecting with Elizabeth on LinkedIn. @lizzymitch2 of @PBGHealth discusses #TPA and #healthplan vs. #jumboemployer inertia on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation Recent past interviews: Click a guest's name for their latest RHV episode! Dave Chase, Jonathan Baran (Part 2), Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode), Dr Stan Schwartz (Summer Shorts), Preston Alexander, Dr Tom X Lee (Take Two: EP445), Dr Tom X Lee (Bonus Episode), Dr Benjamin Schwartz, Dr John Lee (Take Two: EP438), Kimberly Carleson, Ann Lewandowski (Summer Shorts)
“You have to love what you do, especially in healthcare, and the earlier you find that, the better. So that's why I love to see HOSA helping young people find what it is that they want to do,” says Dr. David Kelly, a fellow in oculofacial surgery at University of California San Francisco and HOSA's board chair. You can still hear the excitement in Dr. Kelly's voice describing his earliest experiences with HOSA -- a student led organization with 300,000 plus members that prepares future health professionals to become leaders in international health – even though they happened sixteen years ago when he was a sophomore in highschool. Through hundreds of competitive events and hands-on projects, HOSA creates a framework for developing skills in communication, professionalism and leadership starting in middle school. Programs are offered throughout highschool and college as well, which Dr. Kelly took advantage of before becoming an active alumnus and joining the HOSA board as a way of giving back to an organization that has given so much to him. Since taking the reins as board chair last year, one key focus has been preparing to mark HOSA's 50th anniversary in 2026. Dr. Kelly sees the occasion as not only an opportunity to celebrate what HOSA has accomplished, but to ensure it is positioned to continue helping the healthcare industry tackle important challenges in the future. Examples include chronic workforce shortages and improving how clinicians communicate with patients and team members. Join host Lindsey Smith on this uplifting Raise the Line episode for an optimistic look at the next generation of healthcare leaders.Mentioned in this episode:HOSAHOSA Alumni Registration If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
Host: Braydon Gear Guest: Dr. Shannon Keel Air date: Aug 26, 2025
Did you know that nearly one in three people with obesity may have fatty liver disease without even knowing it? In this episode, I talk about groundbreaking news in obesity and liver health, focusing on the FDA's recent approval of WeGovy to treat metabolic dysfunction associated steatohepatitis (MASH) with moderate to advanced fibrosis. I share a personal story about a friend who once struggled with fatigue, abnormal liver tests, and fatty liver disease, highlighting how limited treatment options used to be. I explain what MASH is, why it's so serious, and how common it is, especially among people with obesity and metabolic syndrome. Furthermore, I dive into the ESSENCE trial, which showed that WeGovy not only improved liver inflammation and scarring but in some cases even reversed the disease, all while emphasizing that it works best when combined with lifestyle changes like healthy eating and regular activity. Don't miss this episode where I break down the latest breakthrough in liver and weight loss care that could change your health journey! Episode Highlights: FDA approval of WeGovy for treating MASH with fibrosis The ESSENCE trial results showing improvements in liver health Understanding what MASH is and why it's so common Importance of combining medication with lifestyle changes Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
How do you know when your kidney health needs more than GP care—and how can you make sure you're getting the right tests, referrals, and treatment? In this powerful follow-up to Episode 139, host Dee Moore is once again joined by Dr. Kristin Veighey for Part 2 of “Beyond the GP: Making Primary Care Work for Kidney Health.” Together, they dive deeper into the realities of managing chronic kidney disease (CKD) in the primary care setting, giving patients the tools to advocate for themselves and get the support they need. This episode answers the questions so many patients ask but rarely get clear guidance on: ✅ Know your risk factors – from diabetes, high blood pressure, and heart disease to family history and medications that can affect kidney function. ✅ Why urine tests matter – and why they often reveal problems years before blood tests. ✅ Diabetes and CKD – the number one cause of kidney disease in the UK, and why tighter blood pressure, cholesterol, and glucose targets are essential. ✅ When to push for referral – understanding the Kidney Failure Risk Equation (KFRE), what “CKD stage 4 or 5” really means, and why you don't have to wait until dialysis is on the table. ✅ The role of the multidisciplinary team – how pharmacists, nurses, and other professionals in primary care can help streamline your care and reduce unnecessary appointments. ✅ Targets that protect your kidneys – the real numbers you should be aiming for with blood pressure, cholesterol, and blood sugar.
Defining Moments Podcast: Conversations about Health and Healing
Dr. Ally Hughes, Assistant Professor of Primary Care at Ohio University, joins co-host Dr. Joe Bianco to recount her journey from being diagnosed with type 1 diabetes at age seven to a career as a diabetes and disabilities researcher, educator, and advocate. The conversation reveals that there is more to diabetes than shame, stigma, and medical trauma. Ally sheds light on innovative medical advances and finds hope in social and online networks dedicated to improving the lives of persons with diabetes. You can read Ally's article in Health Communication here: https://doi.org/10.1080/10410236.2024.2375145
“We've been able to show that even by 30 days of age, we can predict with some accuracy if a child is going to have a diagnosis of autism,” says Dr. Geraldine Dawson, sharing one of the recent advancements in early diagnosis being aided by artificial intelligence. Dr. Dawson -- a leading scholar in the field and founding director of the Duke Center for Autism and Brain Development – explains that an AI examination of a child's pattern of visits to medical specialists in its very early life is an objective diagnostic tool that can supplement the current subjective reports from parents which vary in reliability. Another objective diagnostic tool in development uses a smartphone app developed at Duke that takes video of babies watching images and applies AI-aided Computer Vision Analysis to measure for signs of autism. This enlightening Raise the Line conversation with host Lindsey Smith is loaded with the latest understandings about Autism Spectrum Disorder including advancements in early therapeutic interventions, the interplay of genetic and environmental factors, and the role of the mother's health and exposures during pregnancy. You'll learn as well about what Dawson sees as necessary societal shifts in how autism is perceived, the numerous factors contributing to a near tripling of diagnoses over the past two decades, and how early intervention and informed advocacy can make a meaningful difference in the lives of countless families.Mentioned in this episode:Duke Center for Autism and Brain Development If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
We're discussing Direct Primary Care: a Rising Tide for American Healthcare! Faisel and Dan are joined by Dr. Jeffrey Davenport, from One Focus Medical and Direct Primary Care Alliance.Our conversation revolves around recent policy changes in favor of DPC, timely momentum in the alternative care model movement, and finding physician satisfaction after burnout.This episode was recorded live at FUTURE, the AAFP's annual conference! Learn more about FUTURE here: https://www.aafp.org/events/future-conference/2026.html
Featuring articles on lung cancer, vasomotor symptoms in breast cancer, autoimmune pulmonary alveolar proteinosis, and high-risk cutaneous squamous-cell carcinoma; a review article on educational strategies for clinical supervision of AI use; a case report of a woman with fatigue and myalgias; a Sounding Board on vaccine policy in the U.S.; and Perspectives on preventive care at the Supreme Court, regulating private equity in health care, reforming the prescription drug user fee program, and on the consultant.
Nicholas Bagley is a professor of law at the University of Michigan Law School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Bagley. Preventive Care at the Supreme Court. N Engl J Med 2025;393:729-731.
Interview with Anna D. Ratzliff, MD, PhD and Andrew J. Saxon, MD authors of Collaborative Care for Opioid Use Disorder in Primary Care: A Hybrid Type 2 Cluster Randomized Trial. Hosted by John Torous, MD. Related Content: Collaborative Care for Opioid Use Disorder in Primary Care
Interview with Anna D. Ratzliff, MD, PhD and Andrew J. Saxon, MD authors of Collaborative Care for Opioid Use Disorder in Primary Care: A Hybrid Type 2 Cluster Randomized Trial. Hosted by John Torous, MD. Related Content: Collaborative Care for Opioid Use Disorder in Primary Care
Sometimes the most tempting quick fixes, like eating only one type of food, can actually set you back on your health journey. In this episode, I explored the viral TikTok trend known as the watermelon diet, breaking down why it may seem tempting but is ultimately risky and unsustainable. I shared a story about a friend who was pressured to try it and explained how social media can create unrealistic expectations and comparisons. While watermelon has health benefits like hydration, low calories, and vitamins, I highlighted the dangers of relying on it exclusively—nutrient deficiencies, loss of muscle mass, blood sugar spikes, digestive issues, and unsustainable weight loss. I emphasized that real progress comes from balance: eating a variety of nutrient-rich foods, staying consistent with healthy habits, moving in enjoyable ways, managing stress, and prioritizing rest. Most importantly, I reminded listeners to focus on their own journey, celebrate small wins, and not let social media dictate their worth. Tune in to discover the truth behind viral diet trends and learn healthier, lasting ways to reach your goals. Episode Highlights: The rise of the viral watermelon diet on social media Why extreme mono fruit diets are risky and unsustainable Health benefits of watermelon in moderation Nutrient deficiencies and health risks linked to the diet The role of comparison and pressure from social media Science-backed strategies for balanced, long-term weight loss Importance of mindset, consistency, and celebrating small wins Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
We have a wonderful program in store for you on Saturday as The Word on Medicine brings you into the world of primary care medicine as we explore The Future of Primary Care with Drs. Joseph Gravel, Camille Garrison, Jahanvi Kothari, Frankie Carter, and Ibifiri Wilcox. There is so much to unpack in the arena of primary care and this all-star panel does an amazing job – please listen in!
"Burnout and trauma are not mental illnesses. They live in your physiology. They live in your biology. They live very specifically in your nervous system,” Dr. Rola Hallam says with a conviction rooted in her own successful journey to overcome the effects of chronic stress she accumulated during many years on the frontlines of humanitarian crises in Syria and other conflict zones. Out of concern for the multitudes of health professionals who, like herself, spend years carrying the weight of their traumatic experiences without seeking help, or who pursue ineffective remedies for relieving it, Dr. Rola -- as she's known – has shifted her focus to being a trauma and burnout coach. Among her offerings is Beyond Burnout, a twelve-week program that includes multimedia content as well as live coaching and teaching about developing nervous system awareness and regulation. “Most wellness initiatives fail because they're not rewiring the nervous system to come out of survival mode and back into what is called the ventral-vagal state, which is our state of social connection and of healing and repair.” She also stresses that healing is not an individual pursuit, especially for providers who work in a relational field, and teaches about the benefits of borrowing from a colleagues' state of calm and offering them the same. Don't miss this insightful and giving conversation with host Lindsey Smith that covers Dr. Rola's wrenching experiences providing care in desperate conditions, the critically important distinction between empathy and compassion, and how empowering frontline workers to heal their trauma can uplift individuals and empower entire communities. Mentioned in this episode:Dr. Rola CoachingBeyond Burnout AssessmentCanDo - Humanitarian Aid If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
Featuring articles on overweight, obesity and diabetes; lactated Ringer's solution versus normal saline; and spinal muscular atrophy; a review article on metabolic dysfunction–associated steatotic liver disease; a case report of a woman with respiratory failure and abnormal chest imaging; and Perspectives on dismantling public health infrastructure, on progress lost, on private law in American health care, and on the serendipitous dance between life and death.
Dr. Hoffman continues his conversation with Dr. Ramona Wallace.
For many, integrative medicine has become an unattainable luxury, and healthy diet and lifestyle the prerogative of the privileged. Today's guest, Dr. Ramona Wallace, is attempting to change that. Trained conventionally as a DO, she undertook additional training and certification via the Institute for Functional Medicine to broaden her clinical skills. She practices primary care in an underserved community in Kalamazoo, Michigan, where she incorporates diet and lifestyle recommendations to address her patients' chronic conditions. Careful nutritional assessment has revealed that many of her patients, while overtly overweight, are decidedly malnourished. She has documented a wide range of deficiencies—of B vitamins, vitamins A, C, and D, critical minerals like zinc and magnesium, even full-blown scurvy. These are precisely the patients who are most likely to benefit from nutritional support. Discovering obstacles to compliance is a key element to effect their health transformations. Dr. Wallace believes that individualized care is the key to reversing long-standing health conditions. She mentors medical students in the first-of-its-kind Functional Medicine program at a medical school. She has also co-authored a landmark paper arguing for wellness self-care by doctors, to stave off burnout and to help them be better role models for patients.
Tom Frieden is the president and chief executive officer of Resolve to Save Lives and former director of the Centers for Disease Control and Prevention. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T.R. Frieden. Dismantling Public Health Infrastructure, Endangering American Lives. N Engl J Med 2025;393:625-627.
D.O. or Do Not: The Osteopathic Physician's Journey for Premed & Medical Students
Send us a textToday's guest speaker is Chrissa Karagiannis, a fourth year medical student at Touro California College of Osteopathic Medicine, who is currently in the thick of the residency application and interview process for Family Medicine. In today's episode, Chrissa will share with us her experience participating in the National Health Service Corps Scholarship Program, as an excellent way for students interested in primary care specialties to alleviate the financial burdens of becoming a physician. Chrissa will share her journey to osteopathic medical school, and her passion for working with underserved populations, specifically in overdose prevention. Chrissa will share her involvement with SOMA's Overdose Prevention Committee, and her experience with the AACOM Health Policy Internship, advocating for vulnerable populations and focusing on education for overdose training. Ultimately, I was inspired by Chrissa's passion for advocacy and service with the opioid crisis, and I know you will enjoy this episode as much as we did.
In this episode Stacey Richter speaks with Jonathan Baran, CEO of Self Fund Health in a detailed exploration of what they term the 'Flywheel Downward Spiral' of American healthcare costs. The conversation delves into how electronic health records (EHR) and the incentives driving insurers, brokers, and hospital systems contribute to consistently rising healthcare premiums. Key points include how insurers profit from high premiums, the misleading marketing focus on discounts rather than actual costs, and the role of EHR systems in maximizing hospital profits rather than improving patient care. The episode sets the stage for a subsequent discussion on reversing these trends, aiming to align healthcare outcomes with cost reductions. Self Fund Health, I am so pleased to tell you, as I am always so pleased to tell you, did make such a kind offer to help out Relentless Health Value financially. You and the tribe here are really, really great folks who I truly appreciate. Please support Self Fund Health if you are in Wisconsin. This episode is sponsored by Self Fund Health. === LINKS ===
Featuring articles on treatments for chronic kidney disease and type 2 diabetes, bubonic plague, and advanced breast cancer; a review article on hypogonadism; a Clinical Problem-Solving describing gasping for strength; a Medicine and Society on the infant mortality rate; and Perspectives on profit-driven medicine, on lead contamination in Milwaukee schools, on training health communicators, and on ER and becoming a physician.
© 2020-2025 Ivy Podcast Discovery LLC
